Skip to main content
Show Latest Posts:

The 10 Most Recent Messages By Manifest

Take me back to where I was.
  • Date: 2/23/17 4:45 PM
  • Number: 414557
  • Recommendations: 0

Under Armour (UAA)?  "Is it dead, yet?"  "No, we think it's merely a flesh wound."

But make no mistake, that innocent rabbit known as the stock market, or more precisely, the
(Continued...)

  • Date: 2/1/17 8:23 AM
  • Number: 414530
  • Recommendations: 0

It's Groundhog Day Eve ... and no creatures were stirring.  Yet.  Every year we run a stock selection challenge from Groundhog Day-to-Groundhog Day and shopping in late January and the first couple days of February is
(Continued...)

  • Date: 12/22/16 1:53 PM
  • Number: 414482
  • Recommendations: 0

Happy Festivus, Fool Nation.  This week's study selections are looking for a 52-week Festivus Miracle but they're grounded in solid long-term return forecasts and top shelf quality.  We believe there are some
(Continued...)

  • Date: 12/10/16 12:45 PM
  • Number: 414458
  • Recommendations: 0

Our annual Best Small Companies list has delivered approximately 20% returns for 2016 and 2015 while the Wilshire 5000 checked in at 4% or so.  We believe that a blend of faster-growing, smaller, promising companies (think
(Continued...)

  • Date: 12/9/16 1:25 PM
  • Number: 414454
  • Recommendations: 0

We'll add GlaxoSmithKline (GSK) to our long-term CAPS tracking portfolio as a result of this screening technique that seeks the highest year-over-year (2017 vs. 2016) EPS changes -- while sticking to the Best Companies. 
(Continued...)

  • Date: 12/8/16 6:08 PM
  • Number: 414451
  • Recommendations: 0

Every year, we run a stock selection challenge at www.manifestinvesting.com that starts and ends on Groundhog Day, year over year.  There's an individual and
(Continued...)

  • Date: 12/1/16 3:32 PM
  • Number: 414437
  • Recommendations: 0

The Street is wrecked over the Actavis integration and Copaxone competition.  Teva Pharma (TEVA) is a gorilla and the 3-5 year outlook is pretty good.  The Value Line low total return forecast is approximately 15% and
(Continued...)

  • Date: 11/4/16 2:50 PM
  • Number: 414378
  • Recommendations: 0

Adding Mercadolibre (MELI), Mesa Labs (MLAB) and Forward Air (FWRD) to our CAPS tracking portfolio.

(Continued...)

  • Date: 10/14/16 2:23 PM
  • Number: 414343
  • Recommendations: 0

World leader in diabetes solutions.  Our financial analysis summarized at: https://expectingalpha.com/2016/10/07/novo-nordisk-nvo/

  • Date: 6/21/16 2:50 PM
  • Number: 414190
  • Recommendations: 0

A panorama of the stuff we look at ... using Fastenal (FAST) the 4th most widely-followed stock by Manifest Investing subscribers.  (Continued...)

Show Latest Posts:
Total = 10

Take me back to where I was.
Stock Folders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z